BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10807968)

  • 1. Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines.
    Fukao H; Ikeda M; Ichikawa T; Inufusa H; Okada K; Ueshima S; Matsuo O
    Clin Chim Acta; 2000 Jun; 296(1-2):17-33. PubMed ID: 10807968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic regulation in human endothelial cells by fibrinolytic factors.
    Fukao H; Matsuo O
    Semin Thromb Hemost; 2000; 26(1):33-8. PubMed ID: 10805279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
    Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.
    Abou-Agag LH; Aikens ML; Tabengwa EM; Benza RL; Shows SR; Grenett HE; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):155-62. PubMed ID: 11236827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro.
    Addo-Boadu K; Wojta J; Christ G; Hufnagl P; Pehamberger H; Binder BR
    Cancer Lett; 1996 Jun; 103(2):125-9. PubMed ID: 8635147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
    Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
    Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
    Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells.
    Dumler I; Petri T; Schleuning WD
    FEBS Lett; 1994 Apr; 343(2):103-6. PubMed ID: 8168613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclic AMP on urokinase-type plasminogen activator receptor and fibrinolytic factors in a human osteoblast-like cell line.
    Nonaka T; Matsumoto H; Shimada W; Miyagi I; Okada K; Fukao H; Ueshima S; Kikuchi H; Tanaka S; Matsuo O
    Biochim Biophys Acta; 1995 Apr; 1266(1):50-6. PubMed ID: 7718621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
    Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
    Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.